PubRank

Robert N Davidson

Author PubWeight™ 55.03‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet 2011 4.73
2 A single dose of vitamin D enhances immunity to mycobacteria. Am J Respir Crit Care Med 2007 4.07
3 Characterization and management of paradoxical upgrading reactions in HIV-uninfected patients with lymph node tuberculosis. Clin Infect Dis 2005 3.35
4 IFN-gamma- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37. J Immunol 2007 2.75
5 Neutrophil-mediated innate immune resistance to mycobacteria. J Clin Invest 2007 2.38
6 A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection. Clin Infect Dis 2006 2.29
7 Liposomal amphotericin B for the treatment of visceral leishmaniasis. Clin Infect Dis 2006 2.17
8 Effect of treatment of latent tuberculosis infection on the T cell response to Mycobacterium tuberculosis antigens. J Infect Dis 2005 2.07
9 Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. Proc Natl Acad Sci U S A 2012 2.05
10 Evaluation of a mass distribution programme for fine-mesh impregnated bednets against visceral leishmaniasis in eastern Sudan. Trop Med Int Health 2007 1.89
11 Unseen Kala-azar deaths in south Sudan (1999-2002). Trop Med Int Health 2006 1.83
12 Evaluation of a new recombinant K39 rapid diagnostic test for Sudanese visceral leishmaniasis. Am J Trop Med Hyg 2006 1.72
13 Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome. Clin Infect Dis 2008 1.66
14 Field evaluation of rK39 test and direct agglutination test for diagnosis of visceral leishmaniasis in a population with high prevalence of human immunodeficiency virus in Ethiopia. Am J Trop Med Hyg 2009 1.58
15 Comparison of bronchoscopy and gastric washings in the investigation of smear-negative pulmonary tuberculosis. Clin Infect Dis 2003 1.53
16 Ethnic variation in inflammatory profile in tuberculosis. PLoS Pathog 2013 1.39
17 Limited effectiveness of high-dose liposomal amphotericin B (AmBisome) for treatment of visceral leishmaniasis in an Ethiopian population with high HIV prevalence. Clin Infect Dis 2011 1.38
18 Prospective study of sputum induction, gastric washing, and bronchoalveolar lavage for the diagnosis of pulmonary tuberculosis in patients who are unable to expectorate. Clin Infect Dis 2007 1.36
19 1alpha,25-dihydroxyvitamin D3 inhibits matrix metalloproteinases induced by Mycobacterium tuberculosis infection. Immunology 2008 1.33
20 Treatment of kala-azar in southern Sudan using a 17-day regimen of sodium stibogluconate combined with paromomycin: a retrospective comparison with 30-day sodium stibogluconate monotherapy. Am J Trop Med Hyg 2007 1.28
21 Developments in the treatment of visceral leishmaniasis. Expert Opin Emerg Drugs 2009 1.23
22 Etiology and management of genitourinary tuberculosis. Nat Rev Urol 2011 1.23
23 Rapid molecular detection of rifampicin resistance facilitates early diagnosis and treatment of multi-drug resistant tuberculosis: case control study. PLoS One 2008 1.19
24 Frequencies of region of difference 1 antigen-specific but not purified protein derivative-specific gamma interferon-secreting T cells correlate with the presence of tuberculosis disease but do not distinguish recent from remote latent infections. Infect Immun 2009 1.01
25 Visceral leishmaniasis relapse in Southern Sudan (1999-2007): a retrospective study of risk factors and trends. PLoS Negl Trop Dis 2010 1.01
26 Efficient Ex vivo stimulation of Mycobacterium tuberculosis-specific T cells by genetically detoxified Bordetella pertussis adenylate cyclase antigen toxoids. Infect Immun 2005 0.95
27 Diagnosis and treatment strategies of tuberculous intestinal perforations: a case series. Eur J Gastroenterol Hepatol 2012 0.92
28 Treatment options for visceral leishmaniasis. Expert Rev Anti Infect Ther 2006 0.92
29 Intravenous artesunate versus intravenous quinine in the treatment of severe falciparum malaria: a retrospective evaluation from a UK centre. Pathog Glob Health 2012 0.91
30 First case of typical Old World cutaneous leishmaniasis treated with miltefosine. Int J Dermatol 2007 0.88
31 Leishmania major promastigotes inhibit dendritic cell motility in vitro. Infect Immun 2002 0.87
32 Extra-pulmonary tuberculosis developing at sites of previous trauma. J Infect 2012 0.77
33 Itraconazole in the treatment of New World mucocutaneous leishmaniasis. Int J Dermatol 2004 0.76
34 Comment on "Thwaites et al., 2005, The influence of HIV infection on clinical presentation, response to treatment, and outcome in adults with Tuberculous meningitis" J Infect Dis. 2005 Dec 15;192(12):2134-41. J Infect 2006 0.75